Trials / Conditions / Eyelash Hypotrichosis
Eyelash Hypotrichosis
7 registered clinical trials studyying Eyelash Hypotrichosis.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Safety and Patient Satisfaction With GLASH VISTA™ (Bimatoprost 0.03%) in the Treatment of Eyelash Hypotrichosi NCT02505776 | Allergan | — |
| Completed | Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis NCT01391273 | Allergan | Phase 3 |
| Completed | Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis NCT01391286 | Allergan | Phase 3 |
| Completed | An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashe NCT01623479 | Allergan | — |
| Completed | Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children NCT01023841 | Allergan | Phase 4 |
| Completed | Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence NCT01064882 | Allergan | Phase 2 |
| Completed | Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects NCT01229423 | Allergan | Phase 4 |